Seminoma — Trials · CancerIndex

Clinical trials

Registered studies

30 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 16
Recruiting: 8
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Heinrich-Heine University, Duesseldorf
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (4)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01037790	Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer	completed	Phase 2	304	Abramson Cancer Center at Penn MedicineOTHER	1	Mar 11, 2021	clinicaltrials
NCT02272816	Carboplatin AUC-10 With Early PET Scanning in Metastatic Seminoma(Car-PET)	completed	Phase 2	48	Barts & The London NHS TrustOTHER	1	Jan 25, 2019	clinicaltrials